| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | 297,9 k € | -5.2% | 314,3 k € | +18.7% | 264,8 k € | — | — | ||||||||||||||||
| Gross margin | 449,5 k € | +170.2% | 166,3 k € | -39.1% | 273,1 k € | +72.8% | 158,1 k € | -44.6% | 285,5 k € | +155.9% | 111,6 k € | +25.4% | 89,0 k € | +17.3% | 75,9 k € | -9.2% | 83,5 k € | +265.9% | 22,8 k € | -73.7% | 86,8 k € | -14.5% | 101,5 k € | +154.3% | 39,9 k € | +10.0% | 36,3 k € | -59.2% | 88,9 k € | +85.7% | 47,9 k € | -18.0% | 58,4 k € | -18.6% | 71,8 k € | |
| EBITDA | 281,1 k € | +83.3% | 153,4 k € | -42.2% | 265,6 k € | +70.7% | 155,5 k € | -45.1% | 283,4 k € | +159.4% | 109,2 k € | +28.7% | 84,9 k € | +19.7% | 70,9 k € | -5.8% | 75,3 k € | +337.3% | 17,2 k € | -77.6% | 76,9 k € | -16.1% | 91,7 k € | +137.2% | 38,7 k € | +14.2% | 33,9 k € | -61.5% | 87,9 k € | +97.2% | 44,6 k € | -22.5% | 57,5 k € | -19.5% | 71,4 k € | |
| Operating profit | 267,3 k € | +95.4% | 136,8 k € | -44.9% | 248,2 k € | +79.4% | 138,3 k € | -46.4% | 257,9 k € | +207.5% | 83,9 k € | +54.5% | 54,3 k € | +22.7% | 44,2 k € | -9.6% | 48,9 k € | +576.9% | -10,3 k € | -150.6% | 20,3 k € | -20.9% | 25,6 k € | +8.9% | 23,5 k € | +14.0% | 20,6 k € | -75.1% | 82,9 k € | +92.3% | 43,1 k € | -23.6% | 56,5 k € | -19.1% | 69,8 k € | |
| Profit/loss | 197,4 k € | +102.3% | 97,6 k € | -43.1% | 171,4 k € | +80.2% | 95,1 k € | -46.2% | 176,9 k € | +155.1% | 69,4 k € | +144.8% | 28,3 k € | +6.6% | 26,6 k € | -8.0% | 28,9 k € | +271.0% | -16,9 k € | -381.1% | 6,0 k € | -17.7% | 7,3 k € | -36.6% | 11,5 k € | +22.9% | 9,4 k € | -83.7% | 57,4 k € | +62.0% | 35,4 k € | -2.2% | 36,2 k € | -17.6% | 44,0 k € | |
| Equity | 853,8 k € | +30.1% | 656,4 k € | +1.1% | 649,3 k € | +12.4% | 577,9 k € | +19.7% | 482,8 k € | +57.8% | 305,8 k € | +29.3% | 236,5 k € | +13.6% | 208,1 k € | +14.6% | 181,6 k € | +18.9% | 152,7 k € | -10.0% | 169,6 k € | +3.7% | 163,6 k € | +4.7% | 156,3 k € | +8.0% | 144,8 k € | +6.9% | 135,4 k € | +73.5% | 78,0 k € | -15.7% | 92,6 k € | +64.3% | 56,4 k € | |
| Total assets | 1,0 M € | +26.6% | 790,4 k € | -1.8% | 804,8 k € | +2.7% | 783,4 k € | +11.2% | 704,6 k € | +40.5% | 501,5 k € | +11.3% | 450,5 k € | -4.3% | 470,8 k € | -9.1% | 517,7 k € | +19.6% | 433,0 k € | -12.8% | 496,3 k € | -14.3% | 579,5 k € | +230.1% | 175,5 k € | -6.1% | 187,0 k € | +16.4% | 160,7 k € | -1.0% | 162,3 k € | +9.5% | 148,2 k € | -27.4% | 204,2 k € | |
| Cash | 259,1 k € | +145.6% | 105,5 k € | -4.6% | 110,6 k € | -71.4% | 386,5 k € | +20.3% | 321,4 k € | +191.3% | 110,3 k € | +23.7% | 89,2 k € | -8.4% | 97,4 k € | +5.0% | 92,8 k € | +64.7% | 56,3 k € | -39.0% | 92,4 k € | -23.4% | 120,5 k € | +118.7% | 55,1 k € | -23.9% | 72,5 k € | +179.2% | 25,9 k € | -40.9% | 43,9 k € | -13.0% | 50,5 k € | -51.4% | 103,8 k € | |
| Debts | 144,7 k € | +8.0% | 134,0 k € | -13.8% | 155,6 k € | -24.3% | 205,5 k € | -6.5% | 219,8 k € | +12.3% | 195,7 k € | -8.6% | 214,0 k € | -18.5% | 262,7 k € | -21.8% | 336,1 k € | +19.9% | 280,3 k € | +7.4% | 260,9 k € | +270.3% | 70,5 k € | +265.9% | 19,3 k € | -54.5% | 42,3 k € | +66.9% | 25,3 k € | -69.5% | 82,9 k € | +52.9% | 54,2 k € | -63.3% | 147,8 k € | |
| Staff | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | — | — | — | — | — | — | ||||||||||||||||||
Private limited company · Lasne · incorporated on 23/05/2007
Private limited company profitable and well capitalised. Cash position rising (+145.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MARBLE PHARMA CONSULT is a Private limited company incorporated in 2007. Its main activity is: Management consultancy activities. Its registered office is in Lasne.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette